You searched for "infection"
Internuclear ophthalmoplegia: a case study
3 June 2024
| Miguel Kurc
|
EYE - General
A 44-year-old patient presents with binocular, mostly horizontal diplopia when fixating on moving objects. This has been ongoing for approximately five years. He is known to have multiple sclerosis and had an episode of optic neuritis six years prior in...
Lucentis for pseudophakic CMO
1 October 2015
| Saruban Pasu
|
EYE - Vitreo-Retinal
Pseudophakic cystoid macular oedema (CMO) develops angiographically in up to 20-30% after uneventful phacoemulsification. This study aimed to evaluate the potential efficacy and safety of intravitreal ranibizumab in patients with pseudophakic CMO after cataract surgery. Seven eyes were included in...
A case report of cavernous sinus syndrome following dental procedure
1 April 2014
| Claire Howard
|
EYE - Neuro-ophthalmology
This case report describes a patient presenting with painful diplopia as a consequence of root canal dental treatment. Following root canal treatment a non-resolving tooth pain led to a decision to extract the tooth, leading to onset of severe periorbital...
Endophthalmitis after intravitreal anti-VEGF injection
1 August 2019
| Sofia Rokerya
|
EYE - Vitreo-Retinal
The authors report the results of a retrospective multicentre study conducted at 17 retina referral centres to investigate the microbial spectrum of endophthalmitis after anti-VEGF injections. A total of 83 cases of culture-positive endophthalmitis (58.4%) were included. The most frequent...
BT outcome for CP and ET
The authors evaluate the clinical outcome of botulinum toxin (BT) injection in the correction of esotropia in 44 patients with cerebral palsy (CP). BT was injected under general anaesthesia without EMG guidance. Of the children, 47.7% were male and mean...Avastin vs. Volon A for diabetic macular oedema
1 June 2014
| Nana Theodorou
|
EYE - Vitreo-Retinal
This prospective randomised interventional clinical trial compared 30 diabetic patients with macular oedema treated with either intravitreal injections of bevacizumab (Avastin) or triamcinolone (Volon A). One group initially received three injections of 2.5 mg Avastin in monthly intervals whilst the...
Intravitreal Skills Course at The Royal College of Ophthalmologists Congress 2023
22 May 2023
-25 May 2023
A team led by Mr Nimish Shah, Consultant Ophthalmologist at the Great Western Hospital (GWH) in Swindon, ran the first practical intravitreal injection skills course at the College Congress in May this year. The session provided an overview of the...
Surgical strategies to manage incomitant strabismus in adults
Incomitant vertical and / or horizontal strabismus is a challenging presentation. Patients are usually symptomatic as the onset is either sudden so they haven’t developed any coping mechanisms or very complex so that any coping mechanisms will not cover all...Factors associated with inferior oblique transposition surgery and occurrence of anti-elevation syndrome
The purpose of this study was to correlate the frequency of anti-elevation syndrome (AES) with the magnitude of the anterior transposition of the inferior oblique. This was a retrospective study of 312 eyes of 170 patients. Mean age at surgery...BT vs primary surgery for infantile esotropia
In this study, the success rate of treatment for infantile esotropia (IET) patients who had surgery because of under correction after botulinum toxin (BT) is compared to those having primary surgery. The study included 52 patients (27 male) with mean...Intravitreal afibercept and ranibizumab for PCV
1 August 2016
| Efrosini Papagiannuli
|
EYE - Vitreo-Retinal
This is a retrospective, interventional series comprising 98 eyes with polypidal choroidal vasculopathy (PCV) with the aim of comparing treatments with afibercept and ranibizumab, highlighting any differences in their efficacy. Case notes and imaging (FFA / ICG / OCT) were...
Intravitreal aflibercept for diabetic macular oedema
1 December 2015
| Brian Ang
|
EYE - Vitreo-Retinal
The VISTA and VIVID randomised phase 3 trial were designed to compare the efficacy and safety of intravitreal aflibercept injections versus laser photocoagulation for diabetic macular oedema (DMO). A total of 872 patients with centrally involving DMO were recruited, and...